Galluppi Stefan 4
4 · LifeMD, Inc. · Filed May 21, 2021
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
Galluppi Stefan
Chief Innovation Officer
Transactions
- Purchase
Common Stock, par value $0.01
2021-05-19$10.40/sh+3,796$39,478→ 3,796 total
Holdings
- 1,649,800(indirect: By LLC)
Common Stock, par value $0.01
Footnotes (1)
- [F1]An audit of the reporting person's indirect holdings resulted in a slight adjustment in shares beneficially owned. The holdings reported on this Form 4 are the correct amount of indirectly held securities beneficially owned.